Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy

F Kiefer, K Mann - Current pharmaceutical design, 2010 - ingentaconnect.com
By updating John Littleton's work published 15 years ago this review summarizes recent
work on pharmacodynamic aspects of acamprosate and the perspective for future …

The clinical pharmacology of acamprosate

NJ Kalk, AR Lingford‐Hughes - British journal of clinical …, 2014 - Wiley Online Library
Acamprosate is one of the few medications licensed for prevention of relapse in alcohol
dependence, and over time it has proved to be significantly, if moderately, effective, safe and …

The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence

BJ Mason, CJ Heyser - Expert opinion on drug safety, 2010 - Taylor & Francis
Importance to the field: Acamprosate, marketed under the brand name Campral®,(Forest
Pharmaceuticals, Inc., Saint Louis, MO, USA; Merck Sante sas, Lyon, France) is an orally …

Safety and efficacy of acamprosate for the treatment of alcohol dependence

SL Yahn, LR Watterson… - … Abuse: Research and …, 2013 - journals.sagepub.com
Acamprosate (calcium acetylhomotaurine) is an amino acid modulator that has displayed
efficacy in some clinical trials in reducing craving and promoting abstinence in alcohol …

Acamprosate in the treatment of alcohol dependence: clinical and economic considerations

BJ Mason, R Crean - Expert Review of Neurotherapeutics, 2007 - Taylor & Francis
Acamprosate has been commercially available in the USA since 2004 to treat alcohol
dependence. Its safety and efficacy have been demonstrated in a number of clinical trials …

Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography–mass spectroscopy: a pharmacokinetic …

A Hammarberg, O Beck, S Eksborg… - Therapeutic drug …, 2010 - journals.lww.com
The central nervous system-active medication acamprosate has been shown to modulate
alcohol-related behavior in both preclinical and clinical studies. Although commonly used in …

Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence

BJ Mason, CJ Heyser - … (Formerly Current Drug Targets-CNS & …, 2010 - ingentaconnect.com
Alcoholism is one of the most prevalent substance dependence disorders in the world.
Advances in research in the neurobiological mechanisms underlying alcohol dependence …

Acamprosate produces its anti-relapse effects via calcium

R Spanagel, V Vengeliene, B Jandeleit… - …, 2014 - nature.com
Alcoholism is one of the most prevalent neuropsychiatric diseases, having an enormous
health and socioeconomic impact. Along with a few other medications, acamprosate …

Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action

P De Witte, J Littleton, P Parot, G Koob - CNS drugs, 2005 - Springer
Acamprosate is an abstinence-promoting drug widely used in the treatment of alcohol
dependence but which has a mechanism of action that has remained obscure for many …

Clinical pharmacokinetics of acamprosate

S Saivin, T Hulot, S Chabac, A Potgieter… - Clinical …, 1998 - Springer
Acamprosate is a new psychotropic drug used in the treatment of alcohol (ethanol)-
dependence. Recent studies suggest that acamprosate inhibits neuronal hyperexcitability by …